May 29, 2019 / 01:00PM GMT
Jonas I. Oxgaard - Sanford C. Bernstein & Co., LLC., Research Division - Senior Analyst
Great pleasure that I host Ed Breen with, well, it says DuPont here. It's still technically DowDuPont for another 4 days. I made a comment offhand a few weeks, months ago that this was the most complicated corporate action in corporate history. And I made that comment offhand, but I've since tried to substantiate it, and I just cannot find one that's been more complicated. The Pharmacia-Upjohn merger/split is close, but not quite.
So we're now, well, some like to call it at the end of that journey. I know Ed likes to say that this is just the beginning of DuPont's journey. We'll talk about that, I suppose. But with that, Ed Breen is going to give a few prepared remarks and then we'll go to Q&A. As always, please write down questions on a little piece of paper, hold them up and one of our assistants will collect them and hand them over to me. With that, Ed?
Edward D. Breen - DuPont de Nemours, Inc. - Executive Chairman
Great. Thank you, Jonas. That didn't seem
DuPont Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
May 29, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers